Dr Reddy's launches generic drug to treat multiple sclerosis in US

The company's product is a therapeutic equivalent generic version of
Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug
firm said in a statement.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-generic-drug-to-treat-multiple-sclerosis-in-us/articleshow/78333782.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Biotecnika Times – Newsletter 25.01.2021 – CSIR Notice, CSIR-CCMB & ILS Hiring, FSSAI Funded